The FDA is moving towards an evidence-based approach in the registration of Covid 19 vaccines

Of new brooms and all that

As the saying goes, new brooms sweep clean. This seems to be the direction that the FDA under the stewardship of FDA Commissioner Dr. Marty Makary and the FDA’s director of  Center for Biologics Evaluation and Research (CBER) Dr. Vinay Prasad proposed.

It is worth watching the 38 minute announcement: An evidence-based approach to covid vaccination that sets out new rules for the licensing of Covid 19 vaccines and the rationale behind it.